BFC-24424-14218
4 vaccinations
4 coded responses
34 check-ins
4 free-text entries
0 call cases
- Sex
- —
- Age at first dose
- 66+
- ZIP prefix
- 146 / NY
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Registered in v-safe
- 2021-02-26
-
2021-02-27
Survey response — days 1–6 daily, dose 1MedDRA: Injection site discomfort — Feeling: Good · Site: PainFree text: It is not really pain at injection site, but is more sore, discomfort at injection site, similar to other injections or vaccinations.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
- 2021-03-17
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: Good · Fatigue or tiredness · Be unable to workFree text: fatigue lasted about 16-20 hrs , from one afternoon into late the next morning. Feeling now back to regular energy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
- 2021-03-29
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: Good · Fatigue or tiredness · Be unable to workFree text: fatigue 2d episode yesterday- Monday late & into night. Felt better again by Tuesday morning.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-10-31
Dose 3 — Pfizer-BioNTech
-
2022-03-26
Survey response — 12 months, dose 2MedDRA: Heavy menstrual bleeding, Malaise, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had a period of 2 weeks , more or less , that I tested positive for Covid-19 on early to mid-February 2022. Symptoms were mild. Later both rapid and PCR tests were negative. No apparent sequalae. *MedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Dose 4 — Pfizer-BioNTech
- 2022-04-24
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-07-18
- 2022-10-17
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-10-31 | Pfizer-BioNTech | No |
| 4 | 2022-04-18 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): It is not really pain at injection site, but is more sore, discomfort at injection site, similar to other injections or vaccinations.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): fatigue lasted about 16-20 hrs , from one afternoon into late the next morning. Feeling now back to regular energy.
Systemic reaction (other): fatigue 2d episode yesterday- Monday late & into night. Felt better again by Tuesday morning.
Release 11 — 12 months, dose 2
Symptoms: Had a period of 2 weeks , more or less , that I tested positive for Covid-19 on early to mid-February 2022. Symptoms were mild. Later both rapid and PCR tests were negative. No apparent sequalae. *
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release